|
|
|
Insider
Information: |
Schuth Alexander O. |
Relationship: |
COFO and Secretary |
City: |
South San Francisco |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
187,341 |
|
Indirect Shares
|
523,749 |
|
|
Direct
Value |
$3,883,579 |
|
|
Indirect Value
|
$10,857,317 |
|
|
Total
Shares |
711,090 |
|
|
Total
Value |
$14,740,896 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
15
|
Stock
price went up :
|
0
|
2
|
Stock
price went down : |
0
|
13
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
-30.3%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Denali Therapeutics Inc. |
DNLI |
COFO and Secretary |
2024-02-14 |
187,341 |
2024-02-14 |
523,749 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
90 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
|
2024-02-13 |
4 |
AS |
$17.29 |
$46,960 |
D/D |
(2,716) |
207,469 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
|
2023-02-08 |
4 |
S |
$30.89 |
$46,984 |
I/I |
(1,521) |
499,902 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
|
2019-02-11 |
4 |
AS |
$18.74 |
$47,622 |
I/I |
(2,500) |
665,089 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
|
2019-12-04 |
4 |
AS |
$18.00 |
$47,808 |
I/I |
(2,656) |
580,710 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
|
2019-01-10 |
4 |
AS |
$19.99 |
$49,975 |
I/I |
(2,500) |
672,589 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
|
2019-02-12 |
4 |
AS |
$19.73 |
$50,192 |
I/I |
(2,500) |
662,589 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
|
2018-12-10 |
4 |
AS |
$20.18 |
$50,450 |
I/I |
(2,500) |
682,589 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
|
2018-12-11 |
4 |
AS |
$20.22 |
$50,550 |
I/I |
(2,500) |
680,089 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
|
2019-01-09 |
4 |
AS |
$20.31 |
$50,775 |
I/I |
(2,500) |
675,089 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
|
2018-12-12 |
4 |
AS |
$20.80 |
$52,000 |
I/I |
(2,500) |
677,589 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
|
2019-01-11 |
4 |
AS |
$20.80 |
$52,000 |
I/I |
(2,500) |
670,089 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
|
2019-03-11 |
4 |
AS |
$21.20 |
$52,635 |
I/I |
(2,475) |
660,114 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
|
2019-05-13 |
4 |
AS |
$21.09 |
$52,725 |
I/I |
(2,500) |
640,089 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
|
2022-02-09 |
4 |
S |
$37.10 |
$52,800 |
I/I |
(1,423) |
460,564 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
|
2023-01-17 |
4 |
OE |
$5.28 |
$52,800 |
I/I |
10,000 |
507,173 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
|
2023-05-15 |
4 |
OE |
$5.28 |
$52,800 |
I/I |
10,000 |
538,691 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
|
2023-07-17 |
4 |
OE |
$5.28 |
$52,800 |
I/I |
10,000 |
538,691 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
|
2019-05-10 |
4 |
AS |
$22.19 |
$55,475 |
I/I |
(2,500) |
642,589 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
|
2023-08-21 |
4 |
S |
$22.59 |
$55,978 |
I/I |
(2,478) |
521,511 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
|
2019-12-04 |
4 |
AS |
$18.00 |
$56,178 |
D/D |
(3,121) |
25,839 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
|
2019-03-12 |
4 |
AS |
$22.40 |
$56,291 |
I/I |
(2,513) |
657,601 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
|
2019-05-09 |
4 |
AS |
$22.86 |
$57,150 |
I/I |
(2,500) |
645,089 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
|
2023-08-23 |
4 |
AS |
$23.17 |
$58,435 |
I/I |
(2,522) |
518,989 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
|
2019-03-13 |
4 |
AS |
$23.60 |
$60,387 |
I/I |
(2,512) |
655,089 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
|
2018-10-02 |
4 |
OE |
$5.28 |
$62,498 |
D/D |
7,043 |
12,961 |
0 |
- |
|
90 Records found
|
|
Page 2 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|